Premium
[S2‐01‐04]: The role of statins in delaying Alzheimer's disease. Circulating cholesterol levels, ApoE genotype and initial dementia severity influence the level of benefit produced by atorvastatin in mild‐to‐moderate AD: Results of the ADCLT
Author(s) -
Sparks D. Larry,
Connor Donald J.,
Sabbagh Marwan N.,
Lopez Jean,
Browne Patrick,
Petersen Bob,
Wasser Dawn,
JohnsonTraver Sherry
Publication year - 2005
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2005.06.321
Subject(s) - medicine , atorvastatin , placebo , dementia , apolipoprotein e , randomized controlled trial , cognitive decline , physical therapy , disease , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom